Pharmaron (Ningbo) Technology Development Co., Ltd. announced that it will receive CNY 775,000,000 in an equity round of funding on January 9, 2020. The transaction will include participation from returning investor Pharmaron Beijing Co., Ltd. (SZSE:300759). Post capital increase, the registered capital of the company will increase from CNY 325,000,000 to CNY 1,100,000,000. The transaction has been approved by board of director's of the company in 25th meeting of the 1st directorate.